The Korean Journal of Pain

The Korean Pain Society (대한통증학회)
권호 표지
DOI QR코드

DOI QR Code

Serum Vitamin D Status in Iranian Fibromyalgia Patients: according to the Symptom Severity and Illness Invalidation

  • Maafi, Alireza Amir (Student Research Center, Razi Hospital, School of Medicine, Guilan University of Medical Sciences) ;
  • Ghavidel-Parsa, Banafsheh (Rheumatology Research Center, Razi Hospital, School of Medicine, Guilan University of Medical Sciences) ;
  • Haghdoost, Afrooz (Student Research Center, Razi Hospital, School of Medicine, Guilan University of Medical Sciences) ;
  • Aarabi, Yasaman (Student Research Center, Razi Hospital, School of Medicine, Guilan University of Medical Sciences) ;
  • Hajiabbasi, Asghar (Rheumatology Research Center, Razi Hospital, School of Medicine, Guilan University of Medical Sciences) ;
  • Masooleh, Irandokht Shenavar (Rheumatology Research Center, Razi Hospital, School of Medicine, Guilan University of Medical Sciences) ;
  • Zayeni, Habib (Rheumatology Research Center, Razi Hospital, School of Medicine, Guilan University of Medical Sciences) ;
  • Ghalebaghi, Babak (Otolaryngology and Head and Neck Surgery Research Center, Iran University of Medical Sciences) ;
  • Hassankhani, Amir (Student Research Center, Razi Hospital, School of Medicine, Guilan University of Medical Sciences) ;
  • Bidari, Ali (Department of Rheumatology, Iran University of Medical Sciences)
  • Received : 2016.02.01
  • Accepted : 2016.05.16
  • Published : 2016.07.01
Download PDF
⟨ Previous Next ⟩

Abstract

Background: This study was designed to assess serum vitamin D status (25-OHD) in the fibromyalgia (FM) patients and to compare it with a healthy control group. It also aimed to investigate the correlation of serum vitamin D level with FM symptom severity and invalidation experiences. Methods: A total of 74 consecutive patients with FM and 68 healthy control participants were enrolled. The eligible FM patients completed the Illness Invalidation Inventory (3*I), the Revised Fibromyalgia Impact Questionnaire (FIQR) and a short-form health survey (SF-12). Venous blood samples were drawn from all participants to evaluate serum 25-OHD levels. Mann-Whitney tests and multiple logistic regression analyses were performed and Spearman's correlations were calculated. Results: 88.4% of FM patients had low levels of serum 25-OHD. FM patients had significantly higher level of serum 25-OHD than the control group ($17.24{\pm}13.50$ and $9.91{\pm}6.47$ respectively, P = 0.0001). There were no significant correlations between serum 25-OHD levels and the clinical measures of disease impact, invalidation dimensions, and health status. Multiple logistic regression analyses revealed that an increased discounting of the disease by the patient's spouse was associated with a 4-fold increased risk for vitamin D deficiency (OR = 4.36; 95% CI, 0.95-19.87, P = 0.05). Conclusions: This study showed that although high rates of vitamin D insufficiency or deficiency were seen among FM patients and healthy non-FM participants, but it seems there was no intrinsic association between FM and vitamin D deficiency. Addressing of invalidation experience especially by the patient's spouse is important in management of FM.

Keywords

References

  1. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-81. https://doi.org/10.1056/NEJMra070553
  2. de Rezende Pena C, Grillo LP, das Chagas Medeiros MM. Evaluation of 25-hydroxyvitamin D serum levels in patients with fibromyalgia. J Clin Rheumatol 2010; 16: 365-9. https://doi.org/10.1097/RHU.0b013e3181fe8a90
  3. Straube S, Derry S, Moore RA, McQuay HJ. Vitamin D for the treatment of chronic painful conditions in adults. Cochrane Database Syst Rev 2010: CD007771.
  4. Tandeter H, Grynbaum M, Zuili I, Shany S, Shvartzman P. Serum 25-OH vitamin D levels in patients with fibromyalgia. Isr Med Assoc J 2009; 11: 339-42.
  5. Warner AE, Arnspiger SA. Diffuse musculoskeletal pain is not associated with low vitamin D levels or improved by treatment with vitamin D. J Clin Rheumatol 2008; 14: 12-6. https://doi.org/10.1097/RHU.0b013e31816356a9
  6. McBeth J, Pye SR, O'Neill TW, Macfarlane GJ, Tajar A, Bartfai G, et al. Musculoskeletal pain is associated with very low levels of vitamin D in men: results from the European Male Ageing Study. Ann Rheum Dis 2010; 69: 1448-52. https://doi.org/10.1136/ard.2009.116053
  7. Heidari B, Shirvani JS, Firouzjahi A, Heidari P, Hajian-Tilaki KO. Association between nonspecific skeletal pain and vitamin D deficiency. Int J Rheum Dis 2010; 13: 340-6. https://doi.org/10.1111/j.1756-185X.2010.01561.x
  8. Plotnikoff GA, Quigley JM. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc 2003; 78: 1463-70. https://doi.org/10.4065/78.12.1463
  9. Armstrong DJ, Meenagh GK, Bickle I, Lee AS, Curran ES, Finch MB. Vitamin D deficiency is associated with anxiety and depression in fibromyalgia. Clin Rheumatol 2007; 26: 551-4. https://doi.org/10.1007/s10067-006-0348-5
  10. Ganji V, Milone C, Cody MM, McCarty F, Wang YT. Serum vitamin D concentrations are related to depression in young adult US population: the Third National Health and Nutrition Examination Survey. Int Arch Med 2010; 3: 29. https://doi.org/10.1186/1755-7682-3-29
  11. McCarty DE, Chesson AL Jr, Jain SK, Marino AA. The link between vitamin D metabolism and sleep medicine. Sleep Med Rev 2014; 18: 311-9. https://doi.org/10.1016/j.smrv.2013.07.001
  12. Schmidt-Wilcke T, Clauw DJ. Fibromyalgia: from pathophysiology to therapy. Nat Rev Rheumatol 2011; 7: 518-27. https://doi.org/10.1038/nrrheum.2011.98
  13. Edwards RR, Almeida DM, Klick B, Haythornthwaite JA, Smith MT. Duration of sleep contributes to next-day pain report in the general population. Pain 2008; 137: 202-7. https://doi.org/10.1016/j.pain.2008.01.025
  14. Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 2003; 89: 552-72. https://doi.org/10.1079/BJN2003837
  15. Kool MB, van Middendorp H, Boeije HR, Geenen R. Understanding the lack of understanding: invalidation from the perspective of the patient with fibromyalgia. Arthritis Rheum 2009; 61: 1650-6. https://doi.org/10.1002/art.24922
  16. Kool MB, van Middendorp H, Lumley MA, Bijlsma JW, Geenen R. Social support and invalidation by others contribute uniquely to the understanding of physical and mental health of patients with rheumatic diseases. J Health Psychol 2013; 18: 86-95. https://doi.org/10.1177/1359105312436438
  17. Bidari A, Hassanzadeh M, Ghavidel Parsa B, Kianmehr N, Kabir A, Pirhadi S, et al. Validation of the 2010 American College of Rheumatology preliminary diagnostic criteria for fibromyalgia in an Iranian population. Rheumatol Int 2013; 33: 2999-3007. https://doi.org/10.1007/s00296-013-2829-6
  18. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010; 62: 600-10. https://doi.org/10.1002/acr.20140
  19. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 1990; 33: 160-72. https://doi.org/10.1002/art.1780330203
  20. Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL. The revised fibromyalgia impact questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther 2009; 11: R120. https://doi.org/10.1186/ar2783
  21. Kool MB, van Middendorp H, Lumley MA, Schenk Y, Jacobs JW, Bijlsma JW, et al. Lack of understanding in fibromyalgia and rheumatoid arthritis: the Illness Invalidation Inventory (3*I). Ann Rheum Dis 2010; 69: 1990-5. https://doi.org/10.1136/ard.2009.123224
  22. Montazeri A, Vahdaninia M, Mousavi SJ, Omidvari S. The Iranian version of 12-item short form health survey (SF-12): factor structure, internal consistency and construct validity. BMC Public Health 2009; 9: 341. https://doi.org/10.1186/1471-2458-9-341
  23. Ghavidel Parsa B, Amir Maafi A, Haghdoost A, Arabi Y, Khojamli M, Chatrnour G, et al. The validity and reliability of the persian version of the revised fibromyalgia impact questionnaire. Rheumatol Int 2014; 34: 175-80. https://doi.org/10.1007/s00296-013-2929-3
  24. Mateos F, Valero C, Olmos JM, Casanueva B, Castillo J, Martinez J, et al. Bone mass and vitamin D levels in women with a diagnosis of fibromyalgia. Osteoporos Int 2014; 25: 525-33. https://doi.org/10.1007/s00198-013-2434-2
  25. Wepner F, Scheuer R, Schuetz-Wieser B, Machacek P, Pieler-Bruha E, Cross HS, et al. Effects of vitamin D on patients with fibromyalgia syndrome: a randomized placebocontrolled trial. Pain 2014; 155: 261-8. https://doi.org/10.1016/j.pain.2013.10.002
  26. Daniel D, Pirotta MV. Fibromyalgia--should we be testing and treating for vitamin D deficiency? Aust Fam Physician 2011; 40: 712-6.
  27. Straube S, Andrew Moore R, Derry S, McQuay HJ. Vitamin D and chronic pain. Pain 2009; 141: 10-3. https://doi.org/10.1016/j.pain.2008.11.010
  28. Kool MB, van Middendorp H, Bijlsma JW, Geenen R. Patient and spouse appraisals of health status in rheumatoid arthritis and fibromyalgia: discrepancies and associations with invalidation. Clin Exp Rheumatol 2011; 29: S63-9.

Cited by

  1. Vitamin D and fibromyalgia: a meta-analysis vol.30, pp.4, 2017, https://doi.org/10.3344/kjp.2017.30.4.250
  2. Association between low bone mineral density and fibromyalgia: a meta-analysis vol.36, pp.11, 2017, https://doi.org/10.1007/s10067-017-3683-9
  3. The association between vitamin D concentration and pain: a systematic review and meta-analysis vol.21, pp.11, 2018, https://doi.org/10.1017/S1368980018000551
  4. Fibromyalgia as a Predictor of Increased Postoperative Complications, Readmission Rates, and Hospital Costs in Patients Undergoing Posterior Lumbar Spine Fusion vol.44, pp.4, 2019, https://doi.org/10.1097/BRS.0000000000002820
  5. Vitamin and mineral status in chronic fatigue syndrome and fibromyalgia syndrome: A systematic review and meta-analysis vol.12, pp.4, 2016, https://doi.org/10.1371/journal.pone.0176631
  6. The role of vitamin D testing and replacement in fibromyalgia: a systematic literature review vol.2, pp.1, 2018, https://doi.org/10.1186/s41927-018-0035-6
  7. Is hypovitaminosis D associated with fibromyalgia? A systematic review vol.78, pp.2, 2016, https://doi.org/10.1093/nutrit/nuz033
  8. Association Between Low Vitamin D Levels and the Greater Impact of Fibromyalgia vol.12, pp.7, 2016, https://doi.org/10.14740/jocmr4136
  9. Fibromyalgia Symptom Severity and Psychosocial Outcomes in Fibromyalgia Patients with Hypovitaminosis D: A Prospective Questionnaire Study vol.21, pp.12, 2020, https://doi.org/10.1093/pm/pnz377